1. 92PVall d'Hebron Institute of Oncology (VHIO) immuno-oncology prognostic index (VIO): A new tool for improved patient (pt) selection in phase I (Ph1) trials with immune checkpoint inhibitors (ICI). (23rd October 2018) Authors: Hierro, C; Matos, I; Martin-Liberal, J; Ochoa De Olza Amat, M; Felip, E; Costa Rivas, M; Vieito Villar, M; Brana, I; Azaro, A; Perez-Gago, M C; Gros, A; Carles, J; Oaknin, A; Macarulla, T; Saura, C; pardo, N; Muñoz-Couselo, E; Tabernero, J; Dienstmann, R; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗